Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab

Hum Vaccin Immunother. 2018;14(11):2802. doi: 10.1080/21645515.2018.1486157. Epub 2018 Jun 29.

Authors

Meltem Polat¹, Selçuk Yüksel², Nuriye Ünal Şahin³

Affiliations

¹ a Pamukkale University School of Medicine , Department of Pediatric Infectious Diseases , Denizli , Turkey.
² b Pamukkale University School of Medicine , Department of Pediatric Rheumatology , Denizli , Turkey.
³ c National Reference Laboratory for Respiratory Pathogens, Microbiology Reference Laboratories Department, Public Health Institution of Turkey , Ankara , Turkey.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibiotic Prophylaxis / methods
Antibodies, Monoclonal, Humanized / adverse effects*
Atypical Hemolytic Uremic Syndrome / drug therapy*
Bacteremia / microbiology
Bacteremia / prevention & control*
Child
Fatal Outcome
Humans
Male
Meningococcal Infections / complications
Meningococcal Infections / microbiology
Meningococcal Infections / prevention & control*
Meningococcal Vaccines / administration & dosage
Neisseria meningitidis, Serogroup Y / isolation & purification
Neisseria meningitidis, Serogroup Y / pathogenicity*
Penicillins / therapeutic use
Treatment Failure

Substances

Antibodies, Monoclonal, Humanized
MenACWY-D vaccine
Meningococcal Vaccines
Penicillins
eculizumab